Google-backed Isomorphic Labs raises $2.1B for AI drug discovery platform
Posted:
Isomorphic Labs, an AI drug discovery and development company, raised $2.1 billion in a Series B funding round led by Thrive Capital.
The raise was also backed by existing investors Alphabet and GV (Google Ventures) and new investors MGX, Temasek, CapitalG and the UK Sovereign AI Fund.
A global expert panel has recently announced that the condition hitherto known as polycystic ovary syndrome (PCOS) will officially undergo a name change to polyendocrine metabolic ovarian syndrome (PMOS).
Previously, doctors would diagnose the condition formerly known as PCOS based…
WhatsApp has introduced private chats with its AI chatbot which not even the tech company will be able to read in a new "incognito" mode.
The technology behind WhatsApp's incognito mode is not the same as the end-to-end encryption the platform uses…
Attendees
Sponsors and Exhibitors
Contact us